Khawaja Shahzad
Psychiatry · Toledo, OHNPI 1629193123
Payments from drug & device makers
Across 445 payments — averaging $16.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- Supernus Pharmaceuticals, Inc.$618
- Axsome Therapeutics, Inc.$503
- AbbVie$488
- Ironshore Pharmaceuticals Inc.$403
- Janssen Scientific Affairs, LLC$400
- plus $4K from 26 others
Across 1 payment — averaging $125.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Indivior Inc.$125
What the payments were for
- Consulting fees$4005%
- Food & beverage$6,96094%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 79 | $1,148 |
| Supernus Pharmaceuticals, Inc. | 34 | $618 |
| Axsome Therapeutics, Inc. | 20 | $503 |
| AbbVie(2 entities) | 28 | $488 |
| Ironshore Pharmaceuticals Inc. | 24 | $403 |
| Janssen Scientific Affairs, LLC | 2 | $400 |
| Corium, LLC | 22 | $385 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $367 |
| Sunovion Pharmaceuticals Inc. | 32 | $351 |
| Tris Pharma Inc | 23 | $342 |
| Alkermes, Inc. | 22 | $334 |
| Johnson & Johnson | 18 | $315 |
| Lundbeck LLC | 17 | $292 |
| Neos Therapeutics, LP | 12 | $161 |
| Neurocrine Biosciences, Inc. | 7 | $149 |
| Vanda Pharmaceuticals Inc. | 8 | $142 |
| E.r. Squibb & Sons, L.L.C. | 8 | $140 |
| Vertical Pharmaceuticals, LLC | 10 | $130 |
| Adlon Therapeutics L.p. | 8 | $127 |
| Indivior Inc. | 7 | $120 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $107 |
| Teva Pharmaceuticals USA, Inc. | 4 | $83 |
| Shire North American Group Inc | 5 | $72 |
| Almatica Pharma LLC | 2 | $38 |
| Neuronetics, Inc. | 4 | $32 |
| Jazz Pharmaceuticals Inc. | 2 | $28 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Avion Pharmaceuticals | 1 | $19 |
| Eisai Inc. | 1 | $17 |
| Harmony Biosciences LLC | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Noven Therapeutics, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$400
How this compares
$7,378 in reported general payments places this provider in the 85th percentile of 1,119 psychiatry providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 18 | $35,357 |
| TrintellixVortioxetine Hydrobromide | 14 | $7,876 |
| Oxcarbazepine | 22 | $590 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $310 |
| Bupropion XlBupropion Hcl | 21 | $302 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $243 |
| Duloxetine Hcl | 22 | $207 |
| Lorazepam | 35 | $137 |
| Escitalopram Oxalate | 11 | $124 |
| Trazodone Hcl | 11 | $83 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $78 |
| Topiramate | 12 | $60 |
| Clonazepam | 12 | $20 |
| Alprazolam | 12 | $19 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $488 | $35,35718 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $367 | $7,87614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,119 psychiatry providers in Ohio.
Other psychiatry in Toledo
- David JahnToledo$519K
- Shishuka MalhotraCanton$15M
- Henry NasrallahCincinnati$3.8M
- Otto DuenoDayton$3.1M
- Diab AlmhanaAvon Lake$2.7M
- Mohamed Abdel AzizWest Chester$2.6M
- Fred RomeoColumbus$2.3M
- Mark WoyshvilleMiddleburg Heights$2.2M
- Amita PatelDayton$2.1M
- Caleb AdlerCincinnati$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.